Coming Off a GLP-1: A Practical Guide

At some point, almost everyone on a GLP-1 wonders the same thing: what happens when I stop? It’s the right question to ask early, ideally before you start, because the answer shapes how you should think about the whole journey. This guide is for someone considering stopping — or planning ahead — who wants a clear, honest read on the regain question and a practical way to approach the transition.

You’ll leave understanding what the trial evidence actually shows about stopping, why these medications are increasingly framed as long-term tools rather than short courses, and how to think about tapering and the habits that determine whether your result holds.

The regain question, honestly

Let’s start with the part people don’t want to hear, because the trial evidence is unusually clear on it.

What the STEP 1 extension found

When the STEP 1 trial ended, researchers followed participants for a year after they stopped semaglutide and lifestyle support (Wilding et al., Diabetes, Obesity and Metabolism, 2022). The result: participants regained about two-thirds of their lost weight within that year — a mean regain of 11.6 percentage points. They didn’t return all the way to baseline (the group held a net 5.6% loss at week 120, and 48% still had at least 5% loss), but the trajectory was firmly upward. Cardiometabolic gains largely reversed too: blood pressure, cholesterol, and HbA1c drifted back toward starting values.

The withdrawal trial that isolates the mechanism

STEP 4 (Rubino et al., JAMA, 2021) tested this more directly. After a 20-week run-in on semaglutide, 803 participants were randomized either to continue the drug or switch to placebo for 48 weeks. Those who continued lost a further 7.9%; those switched to placebo gained 6.9% — a 14.8-percentage-point gap driven almost entirely by stopping.

Stopping a GLP-1 is not like finishing a course of antibiotics. For many people, the medication treats an ongoing condition, and removing it removes the effect. That’s biology, not personal failure.

Why regain happens

The reasons are physiological, not a matter of willpower:

• The medication actively suppresses appetite and alters hunger signaling; remove it and those signals return.
• The body has powerful systems that defend against weight loss, nudging appetite and metabolism toward regain.
• Habits formed with strong appetite suppression are harder to maintain without it.

Understanding this reframes the goal: the question isn’t just “how do I stop,” but “what’s my plan for after.”

Three honest paths

Rather than a single prescription, it helps to see the realistic options and discuss them with your clinician:

1. Long-term maintenance on the medication — increasingly how clinicians frame these drugs, much as you’d manage other chronic conditions continuously. STEP 4 is the strongest evidence that continued treatment holds and extends the result.
2. A lower maintenance dose — some people work with their prescriber to find a reduced dose that holds results with fewer downsides. Evidence here is thinner than for full-dose continuation.
3. Coming off entirely — a real option, but one that benefits from preparation and realistic expectations about regain.

None of these is universally “correct.” The right choice depends on your health, your goals, and a conversation with the person managing your care.

If you’re going to stop: how to think about it

Taper, don’t just quit

Work with your prescriber on the approach rather than stopping abruptly. A gradual reduction may help you gauge how your appetite and weight respond at each step, giving you information instead of a sudden cliff. Note that the trials above stopped the drug rather than formally tapering, so tapering is a reasonable clinical practice more than a proven strategy.

Build the habits before you stop

The strategies that carry a result are the ones already in place while the medication is still helping:

• Protein and resistance training to protect the muscle you kept (or built) on the way down
• An eating pattern you can sustain without the medication’s appetite suppression
• Sleep and stress management, both of which influence appetite and weight regulation
• A monitoring routine so you notice drift early, when small corrections still work

Expect appetite to return — and plan for it

The return of hunger after stopping is expected, not a sign something is wrong. The people who do best tend to anticipate it and have structure in place, rather than relying on willpower to fight a biological signal.

It helps to decide in advance what your response will be if the scale starts climbing. A small, early correction — tightening the eating pattern, leaning on the habits you built — is far easier than waiting until significant regain has already happened. Treat the first few months off the medication as an active phase that needs attention, not a finish line you’ve crossed.

The bottom line

Coming off a GLP-1 is a real decision with a real trade-off: the evidence indicates meaningful regain is common when the medication stops — about two-thirds of lost weight within a year in STEP 1 — because it’s treating an ongoing condition rather than curing it. That’s not a reason to avoid these drugs; it’s a reason to go in with eyes open and to decide deliberately between long-term use, a maintenance dose, or a well-prepared exit. Whatever path you choose, the habits you build while on the medication are what carry the result afterward. Make that plan with your clinician, not on your own.

More in the GLP-1 category and the Learn hub.